We are live on ! Find out more
GE

General Electric Portfolio holdings

AUM $369M
1-Year Est. Return 19.65%
This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
-19.65%
3 Year Est. Return
-47.53%
5 Year Est. Return
-4.4%
10 Year Est. Return
+30.79%
AUM
$38.6B
AUM Growth
+$16.7B
Cap. Flow
+$16.4B
Cap. Flow %
42.31%
Top 10 Hldgs %
60.04%
Holding
228
New
15
Increased
44
Reduced
119
Closed
12

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$17.2B
2
AGN
Allergan plc
AGN
+$216M
3
STT icon
State Street
STT
+$84.9M
4
TGT icon
Target
TGT
+$81.7M
5
C icon
Citigroup
C
+$64.5M

Sector Composition

Rank Sector Weight
1 Financials 54.19%
2 Healthcare 9.49%
3 Industrials 8.47%
4 Technology 6.16%
5 Communication Services 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYF icon
1
Synchrony
SYF
$25.4B
$17.3B 44.81%
+705,270,833
New +$17.2B
GE icon
2
GE Aerospace
GE
$355B
$1.95B 5.06%
15,920,142
-27,597
-0.2% -$3.44M
QCOM icon
3
Qualcomm
QCOM
$175B
$560M 1.45%
7,486,192
-360,618
-5% -$27.6M
AMGN icon
4
Amgen
AMGN
$234B
$533M 1.38%
3,793,487
-175,682
-4% -$22.9M
SLB icon
5
SLB Ltd
SLB
$85.1B
$529M 1.37%
5,199,145
-362,300
-7% -$39.5M
AAPL icon
6
Apple
AAPL
$4.67T
$486M 1.26%
19,288,456
-782,784
-4% -$19.2M
AGN
7
DELISTED
Allergan plc
AGN
$467M 1.21%
1,937,308
+963,306
+99% +$216M
EMC
8
DELISTED
EMC CORPORATION
EMC
$464M 1.2%
15,863,172
+140,361
+0.9% +$4.05M
PEP icon
9
PepsiCo
PEP
$193B
$457M 1.18%
4,910,011
-189,512
-4% -$17.3M
JPM icon
10
JPMorgan Chase
JPM
$951B
$436M 1.13%
7,231,939
-177,751
-2% -$10.4M
GOOG icon
11
Alphabet (Google) Class C
GOOG
$4.19T
$427M 1.11%
14,684,406
+114,153
+0.8% +$3.3M
BIDU icon
12
Baidu
BIDU
$32.9B
$407M 1.05%
1,863,758
-565,527
-23% -$120M
STT icon
13
State Street
STT
$53.1B
$404M 1.05%
5,493,502
+1,192,037
+28% +$84.9M
CME icon
14
CME Group
CME
$103B
$393M 1.02%
4,914,085
-199,413
-4% -$15M
LOW icon
15
Lowe's Companies
LOW
$117B
$390M 1.01%
7,373,793
-603,912
-8% -$30.5M
GILD icon
16
Gilead Sciences
GILD
$181B
$379M 0.98%
3,562,245
-1,830,058
-34% -$179M
JNJ icon
17
Johnson & Johnson
JNJ
$646B
$367M 0.95%
3,439,759
-349,859
-9% -$36.3M
V icon
18
Visa
V
$712B
$349M 0.9%
6,547,356
+733,352
+13% +$39.4M
MON
19
DELISTED
Monsanto Co
MON
$334M 0.87%
2,972,253
-107,103
-3% -$12.5M
COV
20
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$334M 0.86%
3,859,246
-458,516
-11% -$40.6M
AMT icon
21
American Tower
AMT
$82.1B
$330M 0.86%
3,529,062
-279,862
-7% -$26.6M
HON icon
22
Honeywell
HON
$68.9B
$325M 0.84%
3,888,262
-24,727
-0.6% -$2.1M
LBTYK icon
23
Liberty Global Class C
LBTYK
$3.56B
$298M 0.77%
8,969,410
+492,440
+6% +$16.6M
XOM icon
24
ExxonMobil
XOM
$644B
$262M 0.68%
2,784,035
-33,840
-1% -$3.37M
EBAY icon
25
eBay
EBAY
$47B
$252M 0.65%
10,573,666
-257,919
-2% -$5.74M

Similar funds

General Electric's Q3 2014 Portfolio in Review

As of Q3 2014, General Electric held 228 positions worth $38.6B, up 76% from $22B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

General Electric deployed $16.4B of net new capital in Q3 2014, opening 15 new positions and adding to 44 existing holdings. Its largest new stake was Synchrony: 705,270,833 shares worth $17.3B.

By sector, the portfolio is most concentrated in Financials at 54% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $179M trimmed.

  • General Electric's largest Q3 2014 buy was Synchrony: 705,270,833 shares worth $17.3B.
  • General Electric added most to Allergan plc in Q3 2014, an estimated $216M increase.
  • General Electric's biggest Q3 2014 reduction was Gilead Sciences, cutting an estimated $179M.
  • General Electric fully exited Genpact in Q3 2014, selling an estimated $31.1M.
  • General Electric's ten largest holdings make up 60% of its $38.6B portfolio in Q3 2014.
  • General Electric opened 15 new positions and closed 12 in Q3 2014.
  • General Electric's portfolio value rose 76% quarter-over-quarter to $38.6B.

Based on General Electric's 13F filing for Q3 2014, filed 14 Nov 2014.